Aurinia: Q4 Earnings Snapshot

February 28, 2022 GMT

VICTORIA, British Columbia (AP) _ Aurinia Pharmaceuticals Inc. (AUPH) on Monday reported a loss of $33.3 million in its fourth quarter.

On a per-share basis, the Victoria, British Columbia-based company said it had a loss of 25 cents.

The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 26 cents per share.

The biotechnology company posted revenue of $23.4 million in the period, which also topped Street forecasts. Five analysts surveyed by Zacks expected $22.4 million.

For the year, the company reported that its loss widened to $181 million, or $1.40 per share. Revenue was reported as $45.6 million.

Aurinia expects full-year revenue in the range of $115 million to $135 million.

Aurinia shares have dropped 29% since the beginning of the year. The stock has risen 16% in the last 12 months.



This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on AUPH at